Found: 3
Select item for more details and to access through your institution.
Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article